Skip to main content
Premium Trial:

Request an Annual Quote

Nasdaq Warns Vermillion of Noncompliance for Low Bid Price

NEW YORK (GenomeWeb News) – Vermillion said that it has received a non-compliance warning letter from the Nasdaq Stock Market because it has failed to maintain a minimum bid price of $1 over the past 30 business days.
 
Vermillion was previously called Ciphergen. Trading opened for the company under the symbol "VMRL" on August 27, when it was trading at just over $.80 a share.
 
The stock's value ticked up to $.93 a share two days later, after Vermillion published a study showing how a protein biomarker it had developed may help to diagnose peripheral artery disease.
 
Nasdaq has given the company an initial period of 180 calendar days, or until March 4, 2008, to trade above the $1 minimum listing price for 10 or more consecutive business days.
 
The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.